ATE482974T1 - Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke - Google Patents

Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke

Info

Publication number
ATE482974T1
ATE482974T1 AT98959858T AT98959858T ATE482974T1 AT E482974 T1 ATE482974 T1 AT E482974T1 AT 98959858 T AT98959858 T AT 98959858T AT 98959858 T AT98959858 T AT 98959858T AT E482974 T1 ATE482974 T1 AT E482974T1
Authority
AT
Austria
Prior art keywords
hepatitis
virus
enclosure
protein
diagnostic use
Prior art date
Application number
AT98959858T
Other languages
English (en)
Inventor
Geert Maertens
Erik Depla
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of ATE482974T1 publication Critical patent/ATE482974T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98959858T 1997-11-06 1998-11-06 Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke ATE482974T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97870179 1997-11-06
PCT/EP1998/007105 WO1999024466A2 (en) 1997-11-06 1998-11-06 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes

Publications (1)

Publication Number Publication Date
ATE482974T1 true ATE482974T1 (de) 2010-10-15

Family

ID=8231063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959858T ATE482974T1 (de) 1997-11-06 1998-11-06 Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke

Country Status (8)

Country Link
US (3) US6855318B1 (de)
EP (1) EP1028972B1 (de)
JP (1) JP2001522599A (de)
AT (1) ATE482974T1 (de)
AU (1) AU752131C (de)
CA (1) CA2305847A1 (de)
DE (1) DE69841919D1 (de)
WO (1) WO1999024466A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA13092A (en) 2001-04-24 2006-11-10 Innogenetics Nv Constructs and methods for expression of recombinant HCV envelope proteins.
EP2338894A1 (de) * 2002-11-08 2011-06-29 The Administrators of the Tulane Educational Fund Flavivirusfusionsinhibitoren
EP1676856A4 (de) * 2003-09-22 2008-03-05 Greenpeptide Co Ltd Aus dem hepatitis c virus stammendes peptid
JP5642972B2 (ja) 2007-02-21 2014-12-17 ユニバーシティー オブ マサチューセッツＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ Ｃ型肝炎ウイルス（ｈｃｖ）に対するヒト抗体およびその使用
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
WO2011100508A2 (en) * 2010-02-12 2011-08-18 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and compositions related to glycoprotein-immunoglobulin fusions
KR20250048816A (ko) * 2022-10-04 2025-04-10 닛폰세이테츠 가부시키가이샤 방향성 전자 강판 및 그 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032907C (en) * 1989-12-22 2002-05-14 Richard R. Lesniewski Hepatitis c assay
US5747239A (en) 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
IT1249684B (it) * 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
ATE228564T1 (de) * 1991-09-13 2002-12-15 Chiron Corp Zusammensetzung aus mehreren immunreaktiven hepatitis-c-virus-polypeptiden
CA2119013A1 (en) * 1991-09-16 1993-04-01 Richard R. Lesniewski Hepatitis c assay
AU2683792A (en) * 1991-09-16 1993-04-27 Genelabs Technologies, Inc. Peptide based hepatitis c virus immunoassays
ES2287969T3 (es) 1992-03-06 2007-12-16 Innogenetics N.V. Peptidos de vih.
KR100312534B1 (ko) * 1993-04-28 2002-05-13 성재갑 씨(c)형간염및비(b)형간염동시측정면역블롯검정키트및면역블롯검정법
CA2175692A1 (en) * 1993-11-04 1995-05-11 Geert Leroux-Roels Immunodominant human t-cell epitopes of hepatitis c virus
ES2170152T3 (es) * 1994-05-20 2002-08-01 Genelabs Tech Inc Virus de la hepatitis g y clon molecular del mismo.
SG71728A1 (en) * 1994-07-29 2000-04-18 Innogenetics Nv Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

Also Published As

Publication number Publication date
DE69841919D1 (de) 2010-11-11
AU752131B2 (en) 2002-09-05
US20040126754A1 (en) 2004-07-01
AU752131C (en) 2003-12-04
EP1028972B1 (de) 2010-09-29
US6855318B1 (en) 2005-02-15
AU1560999A (en) 1999-05-31
WO1999024466A3 (en) 1999-07-15
CA2305847A1 (en) 1999-05-20
JP2001522599A (ja) 2001-11-20
WO1999024466A2 (en) 1999-05-20
EP1028972A2 (de) 2000-08-23
US20060078932A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
ES2138784T3 (es) Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
PT717108E (pt) Proteinas pprs recombinantes, estojos (''kits'') de diagnostico e vacinas contendo as referidas proteinas recombinantes
FI894580A0 (fi) Non-a, non-b -hepatitisvirusantigenpeptid.
BR9509421A (pt) Novas sequências de genotipos de vírus de hepatite C e uso como agentes profiláticos terapêuticos e diagnósticos
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
TR200002695T2 (tr) Viral zar proteinlerdeki epitoplar ve bu epitoplara karşı yönlenmiş özel antikorlar: ev sahibi dokuda viral HCV antijenlerinin tespiti için kullanılması.
KR910019641A (ko) 사람 유두종 바이러스(hpv) 18의 단백질상의 혈청 반응성 에피토프
ATE482974T1 (de) Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
WO1992007940A3 (en) Bovine respiratory syncytial virus genes
ATE193893T1 (de) Peptid aus dem inneren des hepatitis-c-virus brauchbar für die stimulation cytotoxischer t- lymphocyten und die diagnose des hcv-kontaktes
TR200003778T2 (tr) Aşıyla indüklenen hepatit B viral kültürü ve kullanım yerleri
TW200513260A (en) Hepatitis C virus derived peptides
ATE109158T1 (de) Rubella-e1 und c peptide.
EP1878797A3 (de) Antigene Peptide zur Gruppierung des Hepatitis-C-Virus, Kit damit und Verfahren zur Gruppierung unter Verwendung dieses Kits
ES2080023A1 (es) Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.
ATE115964T1 (de) Non-a non-b sequenzen.
FR2765688B1 (fr) Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications
ES2165619T3 (es) Analogos de peptidos asociados al melanoma y vacunas contra el melanoma.
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
TR200202169T1 (tr) Tanı ve tedavide kullanım için pürifiye hepatit C virüsü zarf proteinleri.
WO2002089733A3 (en) Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
ATE540052T1 (de) Neue peptide, die epitope des humanen herpesvirus 8 darstellen
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
RU94039528A (ru) Синтетические олигопептиды, обладающие способностью специфически взаимодействовать с антителами к вирусу гепатита с, и способы диагностики гепатита с с использованием этих пептидов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties